Emiko Tsuda

1.6k total citations
25 papers, 447 citations indexed

About

Emiko Tsuda is a scholar working on Neurology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Emiko Tsuda has authored 25 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 6 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Emiko Tsuda's work include Myasthenia Gravis and Thymoma (15 papers), Peripheral Neuropathies and Disorders (10 papers) and Antifungal resistance and susceptibility (6 papers). Emiko Tsuda is often cited by papers focused on Myasthenia Gravis and Thymoma (15 papers), Peripheral Neuropathies and Disorders (10 papers) and Antifungal resistance and susceptibility (6 papers). Emiko Tsuda collaborates with scholars based in Japan. Emiko Tsuda's co-authors include Tomihiro Imai, Kimiaki Utsugisawa, Shingo Konno, Masayuki Masuda, Hiroyuki Murai, Yuriko Nagane, Yasushi Suzuki, Shun Shimohama, Norihiro Suzuki and Shigeaki Suzuki and has published in prestigious journals such as PLoS ONE, Journal of Neurology Neurosurgery & Psychiatry and Clinical Neurophysiology.

In The Last Decade

Emiko Tsuda

24 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emiko Tsuda Japan 13 388 132 27 26 25 25 447
Jo Stevens Netherlands 10 151 0.4× 50 0.4× 19 0.7× 8 0.3× 25 1.0× 15 295
Ali A. Habib United States 10 181 0.5× 35 0.3× 20 0.7× 11 0.4× 44 1.8× 48 345
Nicolas Keller France 8 108 0.3× 123 0.9× 45 1.7× 11 0.4× 9 0.4× 18 322
Sophie Lehnerer Germany 10 200 0.5× 58 0.4× 6 0.2× 6 0.2× 34 1.4× 29 321
Richard Wlodarski United States 4 209 0.5× 64 0.5× 13 0.5× 12 0.5× 3 0.1× 5 268
Thomas A. Lansen United States 11 200 0.5× 25 0.2× 39 1.4× 8 0.3× 50 2.0× 14 375
Marc Waase United States 13 62 0.2× 59 0.4× 22 0.8× 14 0.5× 13 0.5× 16 292
François Lersy France 7 129 0.3× 74 0.6× 23 0.9× 4 0.2× 15 0.6× 22 189

Countries citing papers authored by Emiko Tsuda

Since Specialization
Citations

This map shows the geographic impact of Emiko Tsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emiko Tsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emiko Tsuda more than expected).

Fields of papers citing papers by Emiko Tsuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emiko Tsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emiko Tsuda. The network helps show where Emiko Tsuda may publish in the future.

Co-authorship network of co-authors of Emiko Tsuda

This figure shows the co-authorship network connecting the top 25 collaborators of Emiko Tsuda. A scholar is included among the top collaborators of Emiko Tsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emiko Tsuda. Emiko Tsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Imai, Tomihiro, et al.. (2024). A new method to evaluate staircase phenomenon in skeletal muscle using piezoelectric sensor. Clinical Neurophysiology Practice. 10. 1–9. 1 indexed citations
2.
Ikeda, Kazuna, et al.. (2021). Measurement of excitation-contraction coupling time in critical illness myopathy. Clinical Neurophysiology. 135. 30–36. 5 indexed citations
3.
Nagane, Yuriko, Hiroyuki Murai, Tomihiro Imai, et al.. (2017). Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study. BMJ Open. 7(2). e013278–e013278. 52 indexed citations
4.
Imai, Tomihiro, Kimiaki Utsugisawa, Hiroyuki Murai, et al.. (2017). Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan. Journal of Neurology Neurosurgery & Psychiatry. 89(5). 513–517. 15 indexed citations
5.
Yamamoto, Daisuke, Tomihiro Imai, Emiko Tsuda, et al.. (2017). Effect of local cooling on excitation-contraction coupling in myasthenic muscle: Another mechanism of ice-pack test in myasthenia gravis. Clinical Neurophysiology. 128(11). 2309–2317. 9 indexed citations
6.
Utsugisawa, Kimiaki, Yuriko Nagane, Tetsuya Akaishi, et al.. (2016). Early fast‐acting treatment strategy against generalized myasthenia gravis. Muscle & Nerve. 55(6). 794–801. 51 indexed citations
7.
Akaishi, Tetsuya, Yasushi Suzuki, Tomihiro Imai, et al.. (2016). Response to treatment of myasthenia gravis according to clinical subtype. BMC Neurology. 16(1). 225–225. 31 indexed citations
8.
Konno, Shingo, Shigeaki Suzuki, Masayuki Masuda, et al.. (2015). Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study. PLoS ONE. 10(5). e0126579–e0126579. 23 indexed citations
9.
Yamamoto, Daisuke, Tomihiro Imai, Emiko Tsuda, et al.. (2015). Impaired post-tetanic potentiation of muscle twitch in myasthenia gravis. Clinical Neurophysiology. 127(2). 1689–1693. 4 indexed citations
10.
Yamamoto, Daisuke, Emiko Tsuda, Masaki Saitoh, Tomihiro Imai, & Shun Shimohama. (2014). A case of atypical Tolosa-Hunt syndrome with a contrast enhanced lesion of the oculomotor and trigeminal nerves on MRI. Rinsho Shinkeigaku. 54(11). 903–906.
11.
Suzuki, Shigeaki, Hiroyuki Murai, Tomihiro Imai, et al.. (2014). Quality of life in purely ocular myasthenia in Japan. BMC Neurology. 14(1). 142–142. 28 indexed citations
12.
Imai, Tomihiro, Shigeaki Suzuki, Emiko Tsuda, et al.. (2014). Oral corticosteroid therapy and present disease status in myasthenia gravis. Muscle & Nerve. 51(5). 692–696. 26 indexed citations
13.
Imai, Tomihiro, et al.. (2013). P2-52. Respiratory impairment with preserved diaphragmatic function in ALS. Clinical Neurophysiology. 124(8). e36–e36. 1 indexed citations
14.
Imai, Tomihiro, Emiko Tsuda, Masaki Saitoh, et al.. (2012). Early effect of tacrolimus in improving excitation–contraction coupling in myasthenia gravis. Clinical Neurophysiology. 123(9). 1886–1890. 15 indexed citations
15.
Kokubun, Norito, Masahiro Sonoo, Tomihiro Imai, et al.. (2011). Reference values for voluntary and stimulated single-fibre EMG using concentric needle electrodes: A multicentre prospective study. Clinical Neurophysiology. 123(3). 613–620. 33 indexed citations
16.
Imai, Tomihiro, Emiko Tsuda, Hiroaki Yoshikawa, et al.. (2011). Contribution of anti-ryanodine receptor antibody to impairment of excitation–contraction coupling in myasthenia gravis. Clinical Neurophysiology. 123(6). 1242–1247. 14 indexed citations
17.
Tsuda, Emiko, Tomihiro Imai, Masaki Saitoh, et al.. (2010). Correlation of bite force with excitation–contraction coupling time of the masseter in myasthenia gravis. Clinical Neurophysiology. 121(7). 1051–1058. 13 indexed citations
18.
Imai, Tomihiro, Emiko Tsuda, Akihiro Matsumura, et al.. (2010). Response of Serum Carboxylated and Undercarboxylated Osteocalcin to Risedronate Monotherapy and Combined Therapy with Vitamin K2 in Corticosteroid-Treated Patients: A Pilot Study. Internal Medicine. 49(5). 371–376. 13 indexed citations
19.
Tsuda, Emiko, Tomihiro Imai, Akihiro Matsumura, et al.. (2008). Thyrotoxic Myopathy Mimicking Myasthenic Syndrome Associated with Thymic Hyperplasia. Internal Medicine. 47(5). 445–447. 10 indexed citations
20.
Imai, Tomihiro, et al.. (2005). Lhermitte's Sign in Alcoholic Myelopathy without Portosystemic Shunting: MRI Evaluation. Internal Medicine. 44(2). 153–154. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jo Stevens Breakdown of academic impact, for papers by Ali A. Habib Breakdown of academic impact, for papers by Nicolas Keller Breakdown of academic impact, for papers by Sophie Lehnerer Breakdown of academic impact, for papers by Richard Wlodarski Breakdown of academic impact, for papers by Thomas A. Lansen Breakdown of academic impact, for papers by Marc Waase Breakdown of academic impact, for papers by François Lersy
Rankless by CCL
2026